157 related articles for article (PubMed ID: 27738871)
1. Targeting SUMO-1ylation Contrasts Synaptic Dysfunction in a Mouse Model of Alzheimer's Disease.
Marcelli S; Ficulle E; Iannuzzi F; Kövari E; Nisticò R; Feligioni M
Mol Neurobiol; 2017 Oct; 54(8):6609-6623. PubMed ID: 27738871
[TBL] [Abstract][Full Text] [Related]
2. Regulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer's disease.
Lee L; Dale E; Staniszewski A; Zhang H; Saeed F; Sakurai M; Fa' M; Orozco I; Michelassi F; Akpan N; Lehrer H; Arancio O
Sci Rep; 2014 Dec; 4():7190. PubMed ID: 25448527
[TBL] [Abstract][Full Text] [Related]
3. Protein SUMOylation modulates calcium influx and glutamate release from presynaptic terminals.
Feligioni M; Nishimune A; Henley JM
Eur J Neurosci; 2009 Apr; 29(7):1348-56. PubMed ID: 19344328
[TBL] [Abstract][Full Text] [Related]
4. Profiles of SUMO and ubiquitin conjugation in an Alzheimer's disease model.
McMillan LE; Brown JT; Henley JM; Cimarosti H
Neurosci Lett; 2011 Sep; 502(3):201-8. PubMed ID: 21843595
[TBL] [Abstract][Full Text] [Related]
5. Alteration of global protein SUMOylation in neurons and astrocytes in response to Alzheimer's disease-associated insults.
Maruyama T; Wada H; Abe Y; Niikura T
Biochem Biophys Res Commun; 2018 Jun; 500(2):470-475. PubMed ID: 29660340
[TBL] [Abstract][Full Text] [Related]
6. Aging-related SUMOylation pattern in the cortex and blood plasma of wild type mice.
Ficulle E; Sufian MDS; Tinelli C; Corbo M; Feligioni M
Neurosci Lett; 2018 Mar; 668():48-54. PubMed ID: 29325714
[TBL] [Abstract][Full Text] [Related]
7. Battling Alzheimer's Disease: Targeting SUMOylation-Mediated Pathways.
Martins WC; Tasca CI; Cimarosti H
Neurochem Res; 2016 Mar; 41(3):568-78. PubMed ID: 26227998
[TBL] [Abstract][Full Text] [Related]
8. Receptor trafficking and the regulation of synaptic plasticity by SUMO.
Luo J; Ashikaga E; Rubin PP; Heimann MJ; Hildick KL; Bishop P; Girach F; Josa-Prado F; Tang LT; Carmichael RE; Henley JM; Wilkinson KA
Neuromolecular Med; 2013 Dec; 15(4):692-706. PubMed ID: 23934328
[TBL] [Abstract][Full Text] [Related]
9. Stress-Induced Synaptic Dysfunction and Neurotransmitter Release in Alzheimer's Disease: Can Neurotransmitters and Neuromodulators be Potential Therapeutic Targets?
Jha SK; Jha NK; Kumar D; Sharma R; Shrivastava A; Ambasta RK; Kumar P
J Alzheimers Dis; 2017; 57(4):1017-1039. PubMed ID: 27662312
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow-derived mesenchymal stem cells contribute to the reduction of amyloid-β deposits and the improvement of synaptic transmission in a mouse model of pre-dementia Alzheimer's disease.
Bae JS; Jin HK; Lee JK; Richardson JC; Carter JE
Curr Alzheimer Res; 2013 Jun; 10(5):524-31. PubMed ID: 23036020
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.
Guo L; Tian J; Du H
J Alzheimers Dis; 2017; 57(4):1071-1086. PubMed ID: 27662318
[TBL] [Abstract][Full Text] [Related]
12. Age-related changes of protein SUMOylation balance in the AβPP Tg2576 mouse model of Alzheimer's disease.
Nisticò R; Ferraina C; Marconi V; Blandini F; Negri L; Egebjerg J; Feligioni M
Front Pharmacol; 2014; 5():63. PubMed ID: 24778618
[TBL] [Abstract][Full Text] [Related]
13. Regulation of mGluR7 trafficking by SUMOylation in neurons.
Choi JH; Park JY; Park SP; Lee H; Han S; Park KH; Suh YH
Neuropharmacology; 2016 Mar; 102():229-35. PubMed ID: 26631532
[TBL] [Abstract][Full Text] [Related]
14. Molecular Organization and Regulation of the Mammalian Synapse by the Post-Translational Modification SUMOylation.
Chato-Astrain I; Pronot M; Coppola T; Martin S
Cells; 2024 Feb; 13(5):. PubMed ID: 38474384
[TBL] [Abstract][Full Text] [Related]
15. Reactive Oxygen Species-Mediated Loss of Synaptic Akt1 Signaling Leads to Deficient Activity-Dependent Protein Translation Early in Alzheimer's Disease.
Ahmad F; Singh K; Das D; Gowaikar R; Shaw E; Ramachandran A; Rupanagudi KV; Kommaddi RP; Bennett DA; Ravindranath V
Antioxid Redox Signal; 2017 Dec; 27(16):1269-1280. PubMed ID: 28264587
[TBL] [Abstract][Full Text] [Related]
16. Spatiotemporal distribution of SUMOylation components during mouse brain development.
Hasegawa Y; Yoshida D; Nakamura Y; Sakakibara S
J Comp Neurol; 2014 Sep; 522(13):3020-36. PubMed ID: 24639124
[TBL] [Abstract][Full Text] [Related]
17. First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression.
Cummings DM; Liu W; Portelius E; Bayram S; Yasvoina M; Ho SH; Smits H; Ali SS; Steinberg R; Pegasiou CM; James OT; Matarin M; Richardson JC; Zetterberg H; Blennow K; Hardy JA; Salih DA; Edwards FA
Brain; 2015 Jul; 138(Pt 7):1992-2004. PubMed ID: 25981962
[TBL] [Abstract][Full Text] [Related]
18. SUMO1-conjugation is altered during normal aging but not by increased amyloid burden.
Stankova T; Piepkorn L; Bayer TA; Jahn O; Tirard M
Aging Cell; 2018 Aug; 17(4):e12760. PubMed ID: 29633471
[TBL] [Abstract][Full Text] [Related]
19. Early selective vulnerability of synapses and synaptic mitochondria in the hippocampal CA1 region of the Tg2576 mouse model of Alzheimer's disease.
Balietti M; Giorgetti B; Casoli T; Solazzi M; Tamagnini F; Burattini C; Aicardi G; Fattoretti P
J Alzheimers Dis; 2013; 34(4):887-96. PubMed ID: 23313923
[TBL] [Abstract][Full Text] [Related]
20. The Ubiquitin-Like SUMO System and Heart Function: From Development to Disease.
Mendler L; Braun T; Müller S
Circ Res; 2016 Jan; 118(1):132-44. PubMed ID: 26837744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
